[SARS-COV-2]-VIRUS-LIKE PARTICLE [VLP] VACCINE: COMPOSITIONS, DELIVERY STRATEGIES, METHODS AND USES

    公开(公告)号:WO2022040220A2

    公开(公告)日:2022-02-24

    申请号:PCT/US2021/046353

    申请日:2021-08-17

    Abstract: The present application relates to SARS-CoV-2 virus-like particles (VLP) and related plasmids, compositions, and methods. The VLP can comprise a modified spike glycoprotein, a matrix protein, a nucleoprotein N and an envelope protein of SARS-CoV-2, where the modified spike glycoprotein comprises an SI domain and an S2 domain, and includes one or more modifications. These modifications can include: linking the SI and S2 domains via generation of disulfides bonds between the SI and S2 domains; linking intra-polypeptide and inter-polypeptide S2 helices of the S2 domain; and substitution of one or more non-cysteine residues with a cysteine residue to generate one or more disulfide bonds. The modifications can stabilize a prefusion conformation of the spike glycoprotein and prohibit a transition to a post-fusion structure.

Patent Agency Ranking